Tuesday, October 21, 2014 2:50:56 PM
IBIO price target. IBIO price target.
The US Government orders 50ML Ebola ZMapp vaccines (Source: 10/17 Reuters news) and then 50ml vaccines more.
Vaccine=$200.EACH, IBIO gets 10% (fees, royalties, sale rev)=$20.EA vaccine.
IBIO Revenue = ($20/EA vaccine)*($50ML Vaccines)=$1,000,000,000.U.S.DOLLARS.
US Government orders 50ML more, IBIO gets = $1BL USD more (Billion
with a "B" and IBIO is a BUY)
IBIO market cap=($2BL revenue)*(20x multiple)=$40BL market cap.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=107388048
Ebola crisis is FAR FROM OVER.
EBOLA ZMapp for the USA and the whole world = IBIO market cap will be BIGGER.
THEREFORE, IBIO = $300.USD per share(Three hundred dollars per share).
Go IBIO $$$$$$$$$$$$$
The US Government orders 50ML Ebola ZMapp vaccines (Source: 10/17 Reuters news) and then 50ml vaccines more.
Vaccine=$200.EACH, IBIO gets 10% (fees, royalties, sale rev)=$20.EA vaccine.
IBIO Revenue = ($20/EA vaccine)*($50ML Vaccines)=$1,000,000,000.U.S.DOLLARS.
US Government orders 50ML more, IBIO gets = $1BL USD more (Billion
with a "B" and IBIO is a BUY)
IBIO market cap=($2BL revenue)*(20x multiple)=$40BL market cap.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=107388048
Ebola crisis is FAR FROM OVER.
EBOLA ZMapp for the USA and the whole world = IBIO market cap will be BIGGER.
THEREFORE, IBIO = $300.USD per share(Three hundred dollars per share).
Go IBIO $$$$$$$$$$$$$
Recent IBIO News
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/29/2026 01:11:36 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 04/17/2026 09:13:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/08/2026 01:00:47 PM
- iBio Received Regulatory Clearance to Initiate Its Phase 1 Clinical Trial of IBIO-600 in Australia • GlobeNewswire Inc. • 04/08/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/27/2026 08:05:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/23/2026 11:31:15 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/23/2026 11:30:09 AM
- iBio to Provide an Update on Cardiopulmonary Program Targeting Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction (PH-HFpEF) • GlobeNewswire Inc. • 03/16/2026 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/09/2026 11:04:38 AM
- iBio Reports Preclinical Body Composition Data from Obese Non-Human Primates Treated with IBIO-610, a Potential First-in-Class Treatment for Fat-Selective Weight Loss • GlobeNewswire Inc. • 03/09/2026 11:00:00 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/09/2026 04:15:16 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/06/2026 10:25:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2026 09:49:58 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 02/27/2026 09:23:59 PM
- iBio to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 02/24/2026 12:00:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/17/2026 11:19:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/10/2026 09:16:39 PM
- iBio Reports Q2 Fiscal Year 2026 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 02/10/2026 09:05:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/09/2026 10:29:54 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 01/30/2026 09:10:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2026 11:15:07 AM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 01/30/2026 02:29:29 AM
